Balyasny Asset Management
LONA

Balyasny Asset Management’s LeonaBio Inc LONA Stock Holding History

Balyasny Asset Management’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,252
Closed -$37K – 2765
2022
Q3 		$37K Buy
+1,252
New +$43.2K ﹤0.01% 2507

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BA
Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Balyasny Asset Management's LONA Position: Q4 2022 in Review

Balyasny Asset Management sold out of LeonaBio Inc (LONA) in Q4 2022, closing a stake of 1,252 shares — an estimated $37K sold.

Balyasny Asset Management first reported a position in LONA in Q3 2022 and held it in 1 quarter. The position peaked at $37K in Q3 2022. 92 funds tracked by Wall St. Rank hold LONA as of Q4 2022.

  • Balyasny Asset Management reported no remaining LeonaBio Inc position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 1,252 LeonaBio Inc shares in Q4 2022, an estimated $37K.
  • Balyasny Asset Management first reported a position in LeonaBio Inc in Q3 2022 and held it in 1 quarter.
  • Balyasny Asset Management's LeonaBio Inc position peaked at $37K in Q3 2022.
  • 92 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.